Delivery Order SPE2DB20D2014-SPE2DB24FD18Y

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office division a $45,349.28 firm-fixed-price delivery order contract for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,098.96 to AmerisourceBergen Drug Corp's Corporate Office Division on May 20, 2024. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $3,694.32 Firm Fixed Price Delivery Order contract to supply HUMIRA(CF) PEN 40 MG/0.4 MLS. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $2,770.74 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,901.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $5,663.40 firm fixed-price contract is for the provision of HUMIRA(CF) PEN 40 MG/0.4 MLS medical supplies, with a completion date of April 24, 2024. This order is fulfilled under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the DLA to efficiently...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The $10,175.92 firm fixed-price contract has a period of performance through July 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has a ceiling value of $2,045.85 and an ultimate completion date of October 20, 2023. The contract is not associated with any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $4,609.08 to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this contract, which is not designated as a set-aside. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD18Y
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $24,078.46 and a completion date of September 30, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded various indefinite delivery contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for delivering a broad range of pharmaceutical and medical supplies to support government healthcare programs and facilities.

Generated 12/27/24, 9:16 AM